semaglutide cause kidney issues in Diabetic Disease: Integrating Clinical Evidence with Mechanistic Insights Semaglutide lowers UACR in overweight

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, or GLP-1 RAs

GLP-1 medications may be appropriate for you if you have: Excess weight or obesity (BMI of 27 or higher with weight-related health conditions, or BMI of 30 or higher) Type 2 diabetes or prediabetes Weight-related health conditions (high blood pressure, high cholesterol, sleep apnea) Struggled with traditional diet and exercise approaches Even small amounts of stubborn fat you want to lose Important Contraindications: These medications are not suitable for everyone

The combination of weight loss, improved insulin sensitivity, and direct hepatic metabolic effects positions Retatrutide as a promising therapeutic for the full spectrum of MASLD, from simple steatosis through steatohepatitis

(July 2025)